recent
novel
avianorigin
influenza
viru
emerg
china
associ
lot
human
infect
fatal
case
genet
analysi
viral
genom
reveal
reassort
viru
might
better
adapt
human
avian
influenza
virus
molecular
diagnost
method
thu
urgent
need
public
health
laboratori
studi
sybr
greenbas
onestep
real
time
revers
transcriptionpcr
rtpcr
develop
detect
novel
viru
primer
pair
basi
hemagglutinin
neuraminidas
gene
sequenc
virus
amplifi
subtypespecif
fragment
tm
valu
respect
standard
curv
show
dynam
linear
rang
across
log
unit
rna
copi
number
copi
ml
detect
limit
copi
per
reaction
assay
use
serial
tenfold
dilut
invitro
transcrib
viral
rna
addit
crossreact
observ
season
virus
well
human
respiratori
virus
assay
evalu
viru
infect
clinic
sampl
posit
amplif
signal
obtain
specimen
accord
assay
therefor
establish
sybr
greenbas
real
time
rtpcr
assay
could
provid
rapid
sensit
specif
reliabl
altern
approach
lower
cost
high
throughput
screen
suspect
sampl
human
anim
environ
first
line
public
health
laboratori
citat
zhu
z
fan
h
qi
x
qi
shi
z
et
al
develop
evalu
sybr
greenbas
real
time
rtpcr
assay
detect
emerg
avian
influenza
viru
plo
one
mz
plo
one
wwwplosoneorg
march
three
die
urban
resid
eastern
china
report
infect
novel
avianorigin
influenza
viru
sequenc
analys
reveal
hemagglutinin
ha
neuraminidas
na
gene
emerg
reassort
viru
belong
subtyp
influenza
viru
respect
six
intern
gene
close
relat
avian
virus
increas
number
patient
infect
viru
subsequ
occur
mani
provinc
china
may
total
laboratoryconfirm
case
human
infect
avian
influenza
viru
report
die
novel
viru
infect
associ
sever
clinic
symptom
character
rapidli
progress
pneumonia
acut
respiratori
distress
syndrom
ard
multiorgan
failur
sinc
viru
detect
previous
human
be
anim
possibl
sourc
infect
reservoir
viru
remain
unclear
moreov
sporad
human
infect
viru
date
rais
import
question
whether
viru
persist
evolv
better
adapt
human
whether
limit
even
sustain
humantohuman
transmiss
occur
question
induc
global
public
health
concern
effect
prevent
control
viru
infect
human
develop
rapid
sensit
specif
molecular
diagnost
assay
urgent
need
mani
laboratori
convent
viru
isol
cell
line
timeconsum
thu
delay
detect
effici
specif
antibodi
respons
viru
infect
gener
produc
week
bodi
infect
patient
monoclon
antibodybas
elisa
well
suitabl
earli
diagnost
tool
initi
stage
diseas
contrast
viral
dna
rna
differ
clinic
sampl
appropri
detect
target
acut
phase
infect
even
onset
ill
variou
detect
method
target
viral
nucleic
acid
develop
rapid
identif
viral
diseas
includ
convent
rtpcr
real
time
rtpcr
microarray
examin
electrospray
ioniz
mass
spectrometri
loopmedi
isotherm
amplif
lamp
realtim
rtpcr
becom
popular
molecular
diagnost
approach
clinic
laboratori
owe
simplic
high
sensit
specif
realtim
rtpcr
assay
usual
carri
use
hydrolysi
probe
taqman
sybr
green
fluoresc
dye
compar
taqman
probe
sybr
greenbas
real
time
rtpcr
assay
achiev
detect
effici
lower
cost
thu
also
wide
appli
detect
varieti
virus
present
studi
develop
rapid
sensit
specif
sybr
greenbas
onestep
real
time
rtpcr
assay
molecular
diagnosi
viru
compar
cell
cultur
strategi
immunolog
assay
nucleic
acidtarget
diagnost
procedur
great
advantag
viru
detect
earli
stage
infect
could
facilit
enhanc
epidemiolog
surveil
suspect
human
infect
emerg
influenza
viru
well
dynam
monitor
viral
gene
sequenc
evolut
sinc
origin
natur
reservoir
viru
definit
determin
establish
detect
assay
could
also
provid
simpl
econom
approach
viru
screen
larg
scale
specimen
variou
anim
includ
chicken
duck
gees
pigeon
quail
wild
bird
studi
approv
ethic
committe
jiangsu
provinci
center
diseas
control
prevent
written
inform
consent
use
clinic
sampl
obtain
patient
involv
studi
respiratori
specimen
obtain
patient
influenzalik
ill
maintain
viral
transport
medium
yocon
biotech
beij
china
detect
viru
infect
accord
protocol
provid
world
health
organ
total
clinic
sampl
throatswab
sputum
tracheal
aspir
patient
collect
store
analysi
viru
isol
perform
madindarbi
canin
kidney
cell
day
posit
cell
cultur
supernat
harvest
store
viru
isol
use
refer
viru
viral
rna
extract
ml
cell
cultur
supernat
respiratori
specimen
use
qiasymphoni
viru
bacteria
mini
kit
combin
qiasymphoni
sp
instrument
qiagen
germani
follow
manufactur
instruct
extract
rna
elut
ml
nucleasefre
water
store
use
primer
ha
na
gene
design
base
first
three
genom
sequenc
emerg
viru
deposit
gisaid
epiflu
databas
use
softwar
tabl
version
increas
wide
spectrum
compat
primer
strain
subtyp
influenza
viru
mix
base
introduc
primer
detail
gene
sequenc
known
circul
viru
strain
asian
origin
download
ncbi
influenza
viru
resourc
databas
subsequ
align
primer
blast
base
close
end
primer
differ
subtyp
viral
gene
sequenc
origin
base
would
substitut
mix
base
ensur
full
complement
sever
base
close
end
primer
templat
possibl
addit
number
mix
base
site
within
primer
allow
three
posit
gener
rule
onestep
real
time
quantit
rtpcr
assay
perform
amplifi
ha
na
gene
viru
respect
use
superscript
iii
platinum
sybr
green
one
step
qrtpcr
kit
invitrogen
ca
usa
assay
carri
ml
reaction
mixtur
contain
ml
green
reaction
mix
mm
primer
ml
rox
refer
dye
ml
superscript
iii
rtplatinum
taq
mix
ml
purifi
rna
optim
thermal
cycl
condit
follow
revers
transcript
step
min
initi
denatur
step
min
cycl
pcr
amplif
sec
sec
sec
follow
melt
curv
analysi
program
accord
instrument
document
real
time
rtpcr
reaction
conduct
triplic
abi
prism
sequenc
detect
system
appli
biosystem
ca
usa
rtpcr
amplicon
subject
capillari
electrophoresi
analysi
qiaxcel
system
qiagen
germani
confirm
specif
viral
ha
na
gene
amplifi
viru
isol
use
follow
primer
contain
detect
limit
sybr
green
real
time
rtpcr
assay
determin
test
serial
tenfold
dilut
invitro
transcrib
viral
rna
rang
copiesml
obtain
cyclethreshold
ct
valu
plot
amount
rna
copi
number
construct
standard
curv
specif
assay
develop
detect
viru
evalu
viral
rna
known
genet
clinic
design
specif
forward
revers
primer
detect
ha
na
gene
viru
base
viral
genom
sequenc
first
three
infect
patient
publish
gisaid
epiflu
databas
region
target
primer
pair
nucleotid
ha
sequenc
nucleotid
na
sequenc
respect
shown
figur
order
increas
detect
scope
primer
known
subtyp
avian
influenza
virus
subtyp
fulllength
viral
gene
sequenc
asian
lineag
download
ncbi
influenza
viru
resourc
databas
align
primer
blast
mix
base
use
close
end
primer
differ
nucleotid
found
primer
download
viral
gene
sequenc
figur
detail
primer
sequenc
list
tabl
employ
genom
rna
templat
purifi
viru
isol
initi
valid
experi
optim
anneal
temperatur
set
optim
primer
concentr
mm
ml
reaction
mixtur
amplif
cycl
melt
curv
analysi
reveal
mean
melt
temperatur
tm
specif
amplicon
quit
differ
primerdim
figur
rtpcr
amplif
segment
confirm
length
bp
capillari
electrophoresi
analysi
figur
use
serial
tenfold
dilut
invitro
transcrib
viral
rna
observ
real
time
rtpcr
assay
rna
copi
reaction
templat
could
gener
posit
amplif
signal
examin
rna
copi
figur
ct
valu
correspond
rna
copi
per
reaction
respect
figur
standard
curv
show
dynam
linear
rang
across
least
log
unit
rna
copi
number
linear
regress
analysi
reveal
correl
coeffici
r
slope
valu
assay
slope
valu
assay
figur
specif
sybr
green
real
time
rtpcr
assay
test
genom
rna
panel
viral
posit
isol
neg
amplif
signal
obtain
assay
sever
known
subtyp
human
influenza
viru
includ
season
virus
tabl
also
posit
amplif
signal
produc
assay
appli
detect
human
respiratori
virus
tabl
evalu
abil
develop
assay
detect
clinic
sampl
respiratori
specimen
seven
previous
confirm
patient
infect
viru
use
analysi
real
time
rtpcr
result
show
posit
signal
produc
sampl
examin
moreov
ct
valu
obtain
assay
well
compar
obtain
assay
individu
infect
patient
figur
influenza
viru
negativesens
rna
viru
belong
famili
orthomyxovirida
subtyp
basi
ha
na
glycoprotein
surfac
viru
particl
antigen
classifi
subtyp
respect
human
infect
influenza
viru
gener
confin
ha
subtyp
na
subtyp
wherea
domest
poultri
wild
bird
usual
serv
natur
reservoir
subtyp
crossspeci
transmiss
avian
influenza
virus
poultri
human
report
focus
subtyp
among
highli
pathogen
viru
caus
infect
death
march
viru
infect
associ
fatal
case
netherland
recent
newli
identifi
avianorigin
reassort
influenza
viru
emerg
china
led
increas
number
human
infect
fatal
case
although
moment
potent
evid
sustain
humantohuman
transmiss
genet
analysi
suggest
sever
amino
acid
chang
viral
ha
rna
polymeras
gene
improv
abil
bind
humantyp
receptor
facilit
effici
replic
mammal
highlight
great
threat
human
be
furthermor
real
sourc
infect
reservoir
novel
viru
still
uncertain
despit
fact
one
viru
isol
acquir
chicken
mani
question
mode
transmiss
viral
incub
period
optim
clinic
specimen
laboratori
confirm
spectrum
clinic
ill
remain
determin
therefor
lot
measur
must
taken
effect
prevent
control
outbreak
viru
infect
develop
rapid
molecular
diagnost
assay
top
prioriti
public
health
laboratori
develop
sybr
greenbas
real
time
rtpcr
assay
rapid
identif
novel
viru
although
primer
design
base
sequenc
initi
three
isol
primer
pair
use
studi
suitabl
detect
new
reassort
viru
stain
avail
gisaid
epiflu
databas
sequenc
align
moreov
introduct
mix
base
primer
could
make
possibl
detect
known
circul
influenza
virus
sinc
sybr
green
dye
intercal
nonspecif
dna
primer
dimer
result
usual
analyz
term
amplif
plot
combin
melt
curv
discrimin
nonspecif
amplif
amplicon
assay
uniqu
tm
valu
significantli
differ
primer
dimer
avoid
fals
posit
result
invitro
transcrib
viral
rna
use
elimin
need
handl
contagi
viru
isol
preferenti
appli
test
sensit
variou
viru
diagnost
assay
use
invitro
rna
transcript
ha
na
gene
viru
assay
found
detect
gene
detect
limit
copi
per
reaction
similar
taqman
probebas
assay
present
corman
et
al
specif
assay
subsequ
establish
test
panel
previous
known
influenza
viru
subtyp
well
human
respiratori
virus
specif
amplif
signal
observ
reaction
virus
templat
indic
high
specif
assay
evalu
practic
use
sybr
greenbas
real
time
rtpcr
assay
collect
clinic
sampl
seven
infect
patient
acut
stage
diseas
sampl
readili
amplifi
examin
method
suggest
effect
clinic
practic
besid
diagnosi
clinic
suspect
sampl
develop
real
time
rtpcr
assay
potenti
dynam
monitor
viral
replic
base
seri
specimen
individu
patient
viru
infect
thu
guid
therapeut
strategi
clinic
larg
scale
specimen
need
collect
evalu
diagnost
robust
assay
consid
high
variat
frequenc
sequenc
influenza
virus
nt
develop
taqman
probebas
assay
detect
emerg
viru
reduc
sensit
elev
fals
neg
result
often
encount
probebas
assay
design
detect
highli
variabl
viral
genom
due
fact
presenc
mutat
within
probe
target
region
prevent
anneal
probe
subsequ
hydrolysi
howev
sybr
greenbas
rtpcr
assay
less
influenc
mismatch
probe
independ
also
took
advantag
sybr
green
quantif
account
includ
compar
amplif
perform
taqman
probe
rel
simplic
lower
run
cost
might
appropri
use
first
line
clinic
laboratori
summari
present
sybr
greenbas
real
time
rtpcr
assay
prove
power
tool
rapid
sensit
specif
detect
emerg
viru
could
provid
simpl
econom
altern
approach
high
throughput
screen
suspect
sampl
human
anim
environ
thu
allow
better
pandem
prepared
